On July 5, Nasdaq Notified Alaunos Therapeutics Transfer Of Its Common Stock From Nasdaq Global Select Market To Nasdaq Capital Market Was Approved; Effective At Opening Of Business On July 7, 2023
Portfolio Pulse from Happy Mohamed
Alaunos Therapeutics has been notified by Nasdaq that the transfer of its common stock from the Nasdaq Global Select Market to the Nasdaq Capital Market has been approved. The change will be effective at the opening of business on July 7, 2023.
July 05, 2023 | 8:20 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Alaunos Therapeutics' stock will be transferred from the Nasdaq Global Select Market to the Nasdaq Capital Market, effective July 7, 2023.
The transfer of Alaunos Therapeutics' stock from the Nasdaq Global Select Market to the Nasdaq Capital Market is a neutral event. It doesn't directly impact the company's fundamentals or its stock's intrinsic value. However, it may affect the stock's liquidity and visibility among investors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100